Picture of BLS Pharmaceuticals logo

BXNDA BLS Pharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Bioxyne Signs Exclusive A$7M Manufacturing And Supply Agreement With NectarTek Australia

April 3 (Reuters) - Bioxyne Ltd BXN.AX:

SIGNS EXCLUSIVE A$7M MANUFACTURING AND SUPPLY AGREEMENT WITH NECTARTEK AUSTRALIA

Source text: ID:nASX6vcF0D

Further company coverage: BXN.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BLS Pharmaceuticals

See all news